Literature DB >> 11588465

Hemolysis in stored red blood cell concentrates: modulation by haptoglobin or ulinastatin, a protease inhibitor.

T Nishiyama1, K Hanaoka.   

Abstract

OBJECTIVE: Polymorphonuclear leukocyte elastase may injure various tissues. The release of polymorphonuclear leukocyte elastase induced by various stimuli was reported to be inhibited by a protease inhibitor, ulinastatin. In stored blood preparations, polymorphonuclear leukocyte elastase increases depending on the storage days as hemolysis increases. We hypothesized that polymorphonuclear leukocyte elastase might be one of the factors inducing hemolysis in stored blood. Haptoglobin binds to free hemoglobin to reduce hemolysis. The purpose of the study was to investigate the effects of ulinastatin on hemolysis in blood preparations in comparison with haptoglobin.
DESIGN: In vitro study.
SETTING: Laboratory in a university hospital.
SUBJECTS: Nine 2-day-old packs of red blood cell concentrates (CRC) in 400 mL each of mannitol, adenine, glucose, phosphate, and citrate (MAP) (MAP-CRC) from the Japan Red Cross Society.
INTERVENTIONS: Each MAP-CRC was divided into three different packs of equal amount and was treated with 10 mL of saline (control group), 200 units of haptoglobin, or 50,000 units of ulinastatin. They were stored at 4 degrees C.
MEASUREMENTS AND MAIN RESULTS: Supernatant concentrations of total and free hemoglobin, total haptoglobin, polymorphonuclear leukocyte elastase, and potassium were measured for 25 days. Free haptoglobin concentration was calculated. Total and free hemoglobin concentrations increased significantly depending on the storage days in the control group, whereas haptoglobin and ulinastatin groups showed no increase. Total and free haptoglobin concentrations were significantly higher in the haptoglobin group than in the other two groups. Free haptoglobin concentrations were 0 after 5 days of storage in the control and ulinastatin groups. Polymorphonuclear leukocyte elastase concentrations increased with the increase in storage days without any differences among the three groups. Potassium concentration increased according to the storage and showed the highest value in the control group.
CONCLUSIONS: Adding haptoglobin or ulinastatin to MAP-CRC was useful to suppress hemolysis during storage of the preparation. The polymorphonuclear leukocyte elastase might not be involved in the mechanisms of hemolysis in MAP-CRC stored for 25 days.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588465     DOI: 10.1097/00003246-200110000-00021

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

Review 1.  Red blood cell transfusion in the neurological ICU.

Authors:  Monisha A Kumar
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Evaluation of a red cell leukofilter performance and effect of buffy coat removal on filtration efficiency and post filtration storage.

Authors:  Atul Sonker; Anju Dubey; Rajendra Chaudhary
Journal:  Indian J Hematol Blood Transfus       Date:  2013-04-26       Impact factor: 0.900

3.  Circuit oxygenator contributes to extracorporeal membrane oxygenation-induced hemolysis.

Authors:  Duane C Williams; Jennifer L Turi; Christoph P Hornik; Desiree K Bonadonna; Walter L Williford; Richard J Walczak; Kevin M Watt; Ira M Cheifetz
Journal:  ASAIO J       Date:  2015 Mar-Apr       Impact factor: 2.872

4.  Electrostatic field can preserve red blood cells in stored blood preparations.

Authors:  Tomoki Nishiyama; Dobun Hayashi
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

5.  Changes in polymorphonuclear leukocyte elastase concentrations and hemolysis parameters in patients transfused with different blood preparations, and in the blood preparations themselves.

Authors:  Tomoki Nishiyama
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

6.  Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass.

Authors:  Xiaocou Wang; Qinghua Xue; Fuxia Yan; Jinping Liu; Shoujun Li; Shengshou Hu
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

7.  Ulinastatin reduces postoperative bleeding and red blood cell transfusion in patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Yun-Tai Yao; Neng-Xin Fang; Ding-Hua Liu; Li-Huan Li
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.